Thus, these findings raise the possibility that cGAS-STING signaling in lung cells can exacerbate ALI, and therefore cell therapy (CD11b+-Mɸ) or STING inhibitors are valuable targets for the treatment of ALI pathology in inflammatory conditions. This evidence concerns the gene STING1 and acute respiratory distress syndrome.